Insider Buying — July 22, 2026

Insider Buying — US Stocks (as of 2026-07-22)

Source: SEC EDGAR Form 4 filings. Open-market purchases by executives and directors. Grouped by filing date; trade date shown with days-to-file lag. Sorted by transaction value.

Filed 2026-07-22

TickerCompanySectorInsiderTitleTrade DateSharesPriceValue% From 52wk Low
PBLSParabilis Medicines, Inc.Health CareRA Capital Healthcare Fund LPmaybe director2026-07-20 (+2d)98,433$27.13$2,670,487+22.6%
PBLSParabilis Medicines, Inc.Health CareRA Capital Nexus Fund III, L.P.maybe director2026-07-20 (+2d)98,433$27.13$2,670,487+22.6%
PBLSParabilis Medicines, Inc.Health CareKolchinsky Petermaybe director2026-07-20 (+2d)98,433$27.13$2,670,487+22.6%
PBLSParabilis Medicines, Inc.Health CareShah Rajeev M.maybe director2026-07-20 (+2d)98,433$27.13$2,670,487+22.6%
PBLSParabilis Medicines, Inc.Health CareRA Capital Healthcare Fund LPmaybe director2026-07-22 (+0d)47,250$29.77$1,406,632+22.6%
PBLSParabilis Medicines, Inc.Health CareRA Capital Nexus Fund III, L.P.maybe director2026-07-22 (+0d)47,250$29.77$1,406,632+22.6%
PBLSParabilis Medicines, Inc.Health CareKolchinsky Petermaybe director2026-07-22 (+0d)47,250$29.77$1,406,632+22.6%
PBLSParabilis Medicines, Inc.Health CareShah Rajeev M.maybe director2026-07-22 (+0d)47,250$29.77$1,406,632+22.6%
PBLSParabilis Medicines, Inc.Health CareRA Capital Healthcare Fund LPmaybe director2026-07-21 (+1d)37,723$30.00$1,131,690+22.6%
PBLSParabilis Medicines, Inc.Health CareRA Capital Nexus Fund III, L.P.maybe director2026-07-21 (+1d)37,723$30.00$1,131,690+22.6%
PBLSParabilis Medicines, Inc.Health CareKolchinsky Petermaybe director2026-07-21 (+1d)37,723$30.00$1,131,690+22.6%
PBLSParabilis Medicines, Inc.Health CareShah Rajeev M.maybe director2026-07-21 (+1d)37,723$30.00$1,131,690+22.6%
PBLSParabilis Medicines, Inc.Health CareRA Capital Healthcare Fund LPmaybe director2026-07-20 (+2d)32,987$27.72$914,400+22.6%
PBLSParabilis Medicines, Inc.Health CareRA Capital Nexus Fund III, L.P.maybe director2026-07-20 (+2d)32,987$27.72$914,400+22.6%
PBLSParabilis Medicines, Inc.Health CareKolchinsky Petermaybe director2026-07-20 (+2d)32,987$27.72$914,400+22.6%
PBLSParabilis Medicines, Inc.Health CareShah Rajeev M.maybe director2026-07-20 (+2d)32,987$27.72$914,400+22.6%
PBLSParabilis Medicines, Inc.Health CareRA Capital Healthcare Fund LPmaybe director2026-07-21 (+1d)21,696$27.96$606,620+22.6%
PBLSParabilis Medicines, Inc.Health CareRA Capital Nexus Fund III, L.P.maybe director2026-07-21 (+1d)21,696$27.96$606,620+22.6%
PBLSParabilis Medicines, Inc.Health CareKolchinsky Petermaybe director2026-07-21 (+1d)21,696$27.96$606,620+22.6%
PBLSParabilis Medicines, Inc.Health CareShah Rajeev M.maybe director2026-07-21 (+1d)21,696$27.96$606,620+22.6%
PBLSParabilis Medicines, Inc.Health CareRA Capital Healthcare Fund LPmaybe director2026-07-21 (+1d)6,504$29.17$189,722+22.6%
PBLSParabilis Medicines, Inc.Health CareRA Capital Nexus Fund III, L.P.maybe director2026-07-21 (+1d)6,504$29.17$189,722+22.6%
PBLSParabilis Medicines, Inc.Health CareKolchinsky Petermaybe director2026-07-21 (+1d)6,504$29.17$189,722+22.6%
PBLSParabilis Medicines, Inc.Health CareShah Rajeev M.maybe director2026-07-21 (+1d)6,504$29.17$189,722+22.6%

Filed 2026-07-20

TickerCompanySectorInsiderTitleTrade DateSharesPriceValue% From 52wk Low
GFSGLOBALFOUNDRIES Inc.Information TechnologyHogan Michael JamesChief Strategy Officer2026-07-15 (+5d)12$61.41$737+88.8%

Filed 2026-07-17

TickerCompanySectorInsiderTitleTrade DateSharesPriceValue% From 52wk Low
ELVElevance Health, Inc.Health CareBOUDREAUX GAILPresident and CEO2026-07-17 (+0d)2,045$368.25$753,071+46.8%
ELVElevance Health, Inc.Health CarePERU RAMIRO Gmaybe director2026-07-17 (+0d)1,000$366.05$366,050+46.8%
ELVElevance Health, Inc.Health CareBOUDREAUX GAILPresident and CEO2026-07-17 (+0d)680$366.41$249,159+46.8%

Filed 2026-07-16

TickerCompanySectorInsiderTitleTrade DateSharesPriceValue% From 52wk Low
FISFidelity National Information Services, Inc.Information TechnologyGoldstein Jeffrey Amaybe director2026-07-15 (+1d)1,386$41.39$57,367+11.1%

This content is for informational purposes only and does not constitute financial, investment, or trading advice. Always consult a qualified financial professional before making any investment decisions.